U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 01:06:10 GMT 2023
Edited
by admin
on Sat Dec 16 01:06:10 GMT 2023
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type SCFV
Sequence Origin MOUSE
Sequence Type COMPLETE
Record UNII
4FR53SIF3A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BLINATUMOMAB
DASH   INN   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
AMG103
Code English
BLINCYTO
Brand Name English
blinatumomab [INN]
Common Name English
BLINATUMOMAB [MI]
Common Name English
AMG-103
Code English
MT103
Code English
BLINATUMOMAB [USAN]
Common Name English
BLINATUMOMAB [JAN]
Common Name English
Blinatumomab [WHO-DD]
Common Name English
MT-103
Code English
IMMUNOGLOBULIN, ANTI-(HUMAN CD19 (ANTIGEN)) (SINGLE-CHAIN) FUSION PROTEIN WITH IMMUNOGLOBULIN, ANTI-(HUMAN CD3 (ANTIGEN)) (CLONE 1 SINGLE-CHAIN)
Common Name English
BLINATUMOMAB [VANDF]
Common Name English
MEDI-538
Code English
BLINATUMOMAB [PURPLE BOOK CDER]
Common Name English
MEDI538
Code English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
NCI_THESAURUS C112889
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
WHO-ATC L01XC19
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 203405
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
NDF-RT N0000191421
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
EU-Orphan Drug EU/3/09/650
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
EMA ASSESSMENT REPORTS BLINCYTO (AUTHORIZED: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA)
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 255707
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 261808
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
NCI_THESAURUS C112883
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
NCI_THESAURUS C1454
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 585917
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 261908
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
FDA ORPHAN DRUG 261708
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
Code System Code Type Description
NDF-RT
N0000191422
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY CD19-directed Antibody Interactions [MoA]
MERCK INDEX
m11822
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL1742992
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
NCI_THESAURUS
C62528
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
DAILYMED
4FR53SIF3A
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
RXCUI
1597258
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY RxNorm
CAS
853426-35-4
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
FDA UNII
4FR53SIF3A
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
INN
9028
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
USAN
TT-64
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
SMS_ID
100000128395
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
EVMPD
SUB35403
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
WIKIPEDIA
BLINATUMOMAB
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
DRUG CENTRAL
4915
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
NDF-RT
N0000175618
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY CD3 Receptor Agonists [MoA]
IUPHAR
7384
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
LACTMED
Blinatumomab
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
DRUG BANK
DB09052
Created by admin on Sat Dec 16 01:06:10 GMT 2023 , Edited by admin on Sat Dec 16 01:06:10 GMT 2023
PRIMARY
Related Record Type Details
TARGET->LIGAND
TARGET -> ACTIVATOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC
Molecular Formula CHEMICAL
Volume of Distribution PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL